A treatment that blocks an age-related protein restored cartilage in aging and injured joints by reprogramming existing cells ...

It is a condition that blights the lives of nearly 10 million Britons. Yet treatment options for osteoarthritisare limited.

Long-defined by high prices, shortages and weekly injections, weight loss drugs including Wegovy and Zepbound are expected to ...

In other news, on December 5, Zoetis Inc. (NYSE:ZTS) announced that Health Canada approved Portela™ (relfovetmab injection) for the relief of pain linked to osteoarthritis, or OA, in cats.

Lateral ankle sprains are common among active individuals and, if not managed properly, can result in recurrent sprains, ...

In 2025, the FDA approved 73 first-time generic drugs.  Here are the generics and their indication, in order of approval date: Note: The FDA’s information is current as of Dec. 18. 1. Phytonadione ...

Spyre Therapeutics (SYRE) stock analysis: de-risked pipeline, cash runway to H2 2028, and 2026–2027 Phase 2 catalysts in ...

Medical progress has led to breakthroughs that could help people at every stage of life, from the smallest babies to the most ...

Dave Mustaine insists Megadeth’s farewell is final, saying the band won’t follow the path of legacy acts who retire only to ...

Khaberni - Recently, there have been two promising developments that suggest the possibility of new treatment options in the ...

ANIP's rare disease push, led by Cortrophin Gel, drove 70% sales growth in the first nine months of 2025, lifting revenue outlook.